Iovance Biotherapeutics
The Director, Payer Access Cell Therapy leads strategic account plans to engage regional and national payors, hospitals, and health systems to secure positive medical policies and reimbursement for Iovance's cell therapy products. This role ensures authorized treatment center support, collaborates with cross-functional teams, and drives patient access through payer policy development and stakeholder engagement. The position requires extensive experience in healthcare reimbursement and strong analytical and leadership skills.
Headquarters
San Carlos, California, United States
Company Size
501-1000 employees
Founded
2007
Iovance Biotherapeutics is a clinical-stage biopharmaceutical company developing tumor-infiltrating lymphocyte (TIL) therapies for solid tumors. Its lead product Amtagvi (lifileucel) is being investigated in multiple clinical trials, with manufacturing conducted at the Iovance Cell Therapy Center in Philadelphia, PA, and collaborations with academic and industry partners to advance next-generation TIL platforms.
Iovance Biotherapeutics’ Latest Moves Shape Market Outlook
7 hours ago
A Look At Iovance Biotherapeutics (IOVA) Valuation After Sharp Recent Share Price Momentum
3 days ago
Iovance Biotherapeutics: The High‑Risk Cancer Stock I Think Could Change a Portfolio by 2036
1 week ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Iovance Biotherapeutics.
17% above the average for this role
Iovance Biotherapeutics: Short-Term Pain, Long-Term Gain - I'm Still Bullish After All These Years
1 week ago
Payer Contracting Lead (Cell Gene & Advanced Therapy)
McKesson
Global Head, Pricing and Market Access Cell Therapy
AstraZeneca
Cell Therapy Market Access Manager – Great Lakes
Bristol Myers Squibb
US Market Access Key Account Director (MAx-KAD), Cell Therapy - Florida
Gilead Sciences
Senior Field Reimbursement Specialist- Cell and Gene Therapy/Rare Disease
AmerisourceBergen Drug Corporation
East Regional Director, Cell Therapy Field Market Access
Bristol Myers Squibb